Literature DB >> 24613100

Tetracycline: a cure all?

Robert Kennedy1, Mustansir Alibhai2, Kaveh Shakib3.   

Abstract

Tetracyclines are used to treat a range of oral conditions. Their efficacy in the treatment of periodontitis is well established, and they are authoritatively recommended in the management of avulsed teeth. There is a growing evidence base to support the use of tetracycline to treat recurrent aphthous stomatitis, but its use in white spongy naevus is limited to a handful of case reports. The mechanism of action in these conditions is either unknown or indicated to be through the inhibition of matrix metalloproteinases (MMP). The use of a single agent to treat diverse oral conditions has important implications for oral medicine.
Copyright © 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dental trauma; Periodontitis; Recurrent aphthous stomatitis; Tetracycline; Vesiculobullous; White spongy naevus

Mesh:

Substances:

Year:  2014        PMID: 24613100     DOI: 10.1016/j.bjoms.2014.01.020

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  3 in total

Review 1.  Tetracyclines-An Important Therapeutic Tool for Dermatologists.

Authors:  Malgorzata Orylska-Ratynska; Waldemar Placek; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

2.  Effect of sterile tetracycline ophthalmic ointment as an adjuvant to mechanical debridement on the treatment of peri-implantitis: A randomized controlled clinical trial.

Authors:  Mohammad Taghi Chitsazi; Azin Khorramdel; Mohammad Amin Mesforoush
Journal:  J Adv Periodontol Implant Dent       Date:  2022-06-15

3.  Effect of tetracyclines on pulpal and periodontal healing after tooth replantation: a systematic review of human and animal studies.

Authors:  Mingmei Meng; Yandi Chen; Huidi Ren; Qiong Zhang; Song Chen; Xuedong Zhou; Jing Zou
Journal:  BMC Oral Health       Date:  2021-06-05       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.